Global Drugs of Abuse Testing Systems Market Growth 2025-2031

Publication ID:

LPI04252412

Publication Date:

April 25, 2025

Pages:

112

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Drugs of Abuse Testing Systems market size is predicted to grow from US$ 5611 million in 2025 to US$ 8300 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031.
Drugs of abuse testing systems, often referred to as drug testing systems, are comprehensive sets of procedures, technologies, and tools designed to detect and identify the presence of specific drugs or their metabolites in biological samples, such as urine, blood, saliva, or hair. These systems are commonly used in various settings, including healthcare, workplace testing, sports, law enforcement, and rehabilitation programs, to monitor and confirm drug use or abuse.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淒rugs of Abuse Testing Systems Industry Forecast鈥� looks at past sales and reviews total world Drugs of Abuse Testing Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Drugs of Abuse Testing Systems sales for 2025 through 2031. With Drugs of Abuse Testing Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drugs of Abuse Testing Systems industry.
This Insight Report provides a comprehensive analysis of the global Drugs of Abuse Testing Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drugs of Abuse Testing Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drugs of Abuse Testing Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drugs of Abuse Testing Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drugs of Abuse Testing Systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs of Abuse Testing Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Urine Screening System
Saliva Test System
Others
Segmentation by Application:
Hospital
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Thermo Fisher Scientific
Roche
Siemens Healthineers
Wondfo Biotech
Randox Laboratories
OraSure
Drager
Intec
Orient Gene Biotech
Hangzhou Biotest
Assure Tech (Hangzhou) Co
Aotai Bio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Drugs of Abuse Testing Systems market?
What factors are driving Drugs of Abuse Testing Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drugs of Abuse Testing Systems market opportunities vary by end market size?
How does Drugs of Abuse Testing Systems break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs of Abuse Testing Systems Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Drugs of Abuse Testing Systems by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Drugs of Abuse Testing Systems by Country/Region, 2020, 2024 & 2031
2.2 Drugs of Abuse Testing Systems Segment by Type
2.2.1 Urine Screening System
2.2.2 Saliva Test System
2.2.3 Others
2.3 Drugs of Abuse Testing Systems Sales by Type
2.3.1 Global Drugs of Abuse Testing Systems Sales Market Share by Type (2020-2025)
2.3.2 Global Drugs of Abuse Testing Systems Revenue and Market Share by Type (2020-2025)
2.3.3 Global Drugs of Abuse Testing Systems Sale Price by Type (2020-2025)
2.4 Drugs of Abuse Testing Systems Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.4.3 Others
2.5 Drugs of Abuse Testing Systems Sales by Application
2.5.1 Global Drugs of Abuse Testing Systems Sale Market Share by Application (2020-2025)
2.5.2 Global Drugs of Abuse Testing Systems Revenue and Market Share by Application (2020-2025)
2.5.3 Global Drugs of Abuse Testing Systems Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Drugs of Abuse Testing Systems Breakdown Data by Company
3.1.1 Global Drugs of Abuse Testing Systems Annual Sales by Company (2020-2025)
3.1.2 Global Drugs of Abuse Testing Systems Sales Market Share by Company (2020-2025)
3.2 Global Drugs of Abuse Testing Systems Annual Revenue by Company (2020-2025)
3.2.1 Global Drugs of Abuse Testing Systems Revenue by Company (2020-2025)
3.2.2 Global Drugs of Abuse Testing Systems Revenue Market Share by Company (2020-2025)
3.3 Global Drugs of Abuse Testing Systems Sale Price by Company
3.4 Key Manufacturers Drugs of Abuse Testing Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drugs of Abuse Testing Systems Product Location Distribution
3.4.2 Players Drugs of Abuse Testing Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Drugs of Abuse Testing Systems by Geographic Region
4.1 World Historic Drugs of Abuse Testing Systems Market Size by Geographic Region (2020-2025)
4.1.1 Global Drugs of Abuse Testing Systems Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Drugs of Abuse Testing Systems Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Drugs of Abuse Testing Systems Market Size by Country/Region (2020-2025)
4.2.1 Global Drugs of Abuse Testing Systems Annual Sales by Country/Region (2020-2025)
4.2.2 Global Drugs of Abuse Testing Systems Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drugs of Abuse Testing Systems Sales Growth
4.4 APAC Drugs of Abuse Testing Systems Sales Growth
4.5 Europe Drugs of Abuse Testing Systems Sales Growth
4.6 Middle East & Africa Drugs of Abuse Testing Systems Sales Growth
5 Americas
5.1 Americas Drugs of Abuse Testing Systems Sales by Country
5.1.1 Americas Drugs of Abuse Testing Systems Sales by Country (2020-2025)
5.1.2 Americas Drugs of Abuse Testing Systems Revenue by Country (2020-2025)
5.2 Americas Drugs of Abuse Testing Systems Sales by Type (2020-2025)
5.3 Americas Drugs of Abuse Testing Systems Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs of Abuse Testing Systems Sales by Region
6.1.1 APAC Drugs of Abuse Testing Systems Sales by Region (2020-2025)
6.1.2 APAC Drugs of Abuse Testing Systems Revenue by Region (2020-2025)
6.2 APAC Drugs of Abuse Testing Systems Sales by Type (2020-2025)
6.3 APAC Drugs of Abuse Testing Systems Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Drugs of Abuse Testing Systems by Country
7.1.1 Europe Drugs of Abuse Testing Systems Sales by Country (2020-2025)
7.1.2 Europe Drugs of Abuse Testing Systems Revenue by Country (2020-2025)
7.2 Europe Drugs of Abuse Testing Systems Sales by Type (2020-2025)
7.3 Europe Drugs of Abuse Testing Systems Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs of Abuse Testing Systems by Country
8.1.1 Middle East & Africa Drugs of Abuse Testing Systems Sales by Country (2020-2025)
8.1.2 Middle East & Africa Drugs of Abuse Testing Systems Revenue by Country (2020-2025)
8.2 Middle East & Africa Drugs of Abuse Testing Systems Sales by Type (2020-2025)
8.3 Middle East & Africa Drugs of Abuse Testing Systems Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drugs of Abuse Testing Systems
10.3 Manufacturing Process Analysis of Drugs of Abuse Testing Systems
10.4 Industry Chain Structure of Drugs of Abuse Testing Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drugs of Abuse Testing Systems Distributors
11.3 Drugs of Abuse Testing Systems Customer
12 World Forecast Review for Drugs of Abuse Testing Systems by Geographic Region
12.1 Global Drugs of Abuse Testing Systems Market Size Forecast by Region
12.1.1 Global Drugs of Abuse Testing Systems Forecast by Region (2026-2031)
12.1.2 Global Drugs of Abuse Testing Systems Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Drugs of Abuse Testing Systems Forecast by Type (2026-2031)
12.7 Global Drugs of Abuse Testing Systems Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.1.3 Abbott Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Information
13.2.2 Thermo Fisher Scientific Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.2.3 Thermo Fisher Scientific Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Thermo Fisher Scientific Main Business Overview
13.2.5 Thermo Fisher Scientific Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.3.3 Roche Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Siemens Healthineers
13.4.1 Siemens Healthineers Company Information
13.4.2 Siemens Healthineers Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.4.3 Siemens Healthineers Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Siemens Healthineers Main Business Overview
13.4.5 Siemens Healthineers Latest Developments
13.5 Wondfo Biotech
13.5.1 Wondfo Biotech Company Information
13.5.2 Wondfo Biotech Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.5.3 Wondfo Biotech Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Wondfo Biotech Main Business Overview
13.5.5 Wondfo Biotech Latest Developments
13.6 Randox Laboratories
13.6.1 Randox Laboratories Company Information
13.6.2 Randox Laboratories Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.6.3 Randox Laboratories Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Randox Laboratories Main Business Overview
13.6.5 Randox Laboratories Latest Developments
13.7 OraSure
13.7.1 OraSure Company Information
13.7.2 OraSure Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.7.3 OraSure Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 OraSure Main Business Overview
13.7.5 OraSure Latest Developments
13.8 Drager
13.8.1 Drager Company Information
13.8.2 Drager Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.8.3 Drager Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Drager Main Business Overview
13.8.5 Drager Latest Developments
13.9 Intec
13.9.1 Intec Company Information
13.9.2 Intec Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.9.3 Intec Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Intec Main Business Overview
13.9.5 Intec Latest Developments
13.10 Orient Gene Biotech
13.10.1 Orient Gene Biotech Company Information
13.10.2 Orient Gene Biotech Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.10.3 Orient Gene Biotech Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Orient Gene Biotech Main Business Overview
13.10.5 Orient Gene Biotech Latest Developments
13.11 Hangzhou Biotest
13.11.1 Hangzhou Biotest Company Information
13.11.2 Hangzhou Biotest Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.11.3 Hangzhou Biotest Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hangzhou Biotest Main Business Overview
13.11.5 Hangzhou Biotest Latest Developments
13.12 Assure Tech (Hangzhou) Co
13.12.1 Assure Tech (Hangzhou) Co Company Information
13.12.2 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.12.3 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Assure Tech (Hangzhou) Co Main Business Overview
13.12.5 Assure Tech (Hangzhou) Co Latest Developments
13.13 Aotai Bio
13.13.1 Aotai Bio Company Information
13.13.2 Aotai Bio Drugs of Abuse Testing Systems Product Portfolios and Specifications
13.13.3 Aotai Bio Drugs of Abuse Testing Systems Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Aotai Bio Main Business Overview
13.13.5 Aotai Bio Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂